Ranbaxy Laboratories inches up as its arm launches Absorica Capsules in US

26 Nov 2012 Evaluate

Ranbaxy Laboratories is currently trading at Rs. 497.30, up by 1.35 points or 0.27% from its previous closing of Rs. 495.95 on the BSE.

The scrip opened at Rs. 497.00 and has touched a high and low of Rs. 503.00 and Rs. 490.10 respectively. So far 1, 11,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 578.30 on 04-Sep-2012 and a 52 week low of Rs. 366.50 on 19-Dec-2011.

Last one week high and low of the scrip stood at Rs. 525.00 and Rs. 490.10 respectively. The current market cap of the company is Rs. 21,009 crore.

The promoters holding in the company stood at 63.64% while Institutions and Non-Institutions held 21.20% and 13.15% respectively.

Ranbaxy Laboratories’ (RLL) wholly-owned subsidiary - Ranbaxy Laboratories, Inc. (RLI) has launched Absorica (Isotretinoin) capsules, a product that is licensed from Mississauga, Ontario-based Cipher Pharmaceuticals Inc of Mississauage, Ontario. Absorica is indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older.

Due to its high lipophilicity, oral absorption of isotretinoin is enhanced when given with a high-fat meal. However, Absorica, which is formulated using patented Lidose technology, can be given without regards to meals. The fasted AUCo-t of Absorica is around 83 percent greater than that of Accutane, while both products are bio-equivalent under fed conditions. Absorica is, therefore, not interchangeable and not substitutable with generic products of Accutane. Absorica, NDA, was approved based on a large pivotal clinical trial enrolling 925 patients.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×